調査レポート | • レポートコード：QYR2104Z2297 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、目感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ジェル＆クリーム、点眼薬、治療薬）、用途別市場規模（眼科クリニック、病院、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・目感染症治療の市場動向 ・企業の競争状況、市場シェア ・目感染症治療の種類別市場規模（ジェル＆クリーム、点眼薬、治療薬） ・目感染症治療の用途別市場規模（眼科クリニック、病院、小売薬局、オンライン薬局） ・目感染症治療の北米市場規模2016-2027（アメリカ、カナダ） ・目感染症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・目感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・目感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・目感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Allergan、Mercks、Novartis、Pfizer、Santen Pharmaceuticals、Valent、Bayer、GSK、AstraZeneca、Daiichi Sankyo、Eli Lilly、Novo Nordisk、Sanofi、GSK、Bausch＆Lomb） ・結論 |
Eye infections can be the inflammation of the Conjunctiva (Conjunctivitis), eyelid (blepharitis), the cornea (keratitis), the liquid inside the eye (vitritis), the retina and the blood vessels that feed it (chorioretinitis), or the optic nerve (neuroretinitis).
Eye infections treatment market is growing, this is attributed to aging population, rising prevalence of ophthalmic diseases, increasing company investments for launching new product forms, health conscious population, free eye check-up camps funded by the government in the different regions.
Market Analysis and Insights: Global Eye Infections Treatment Market
The global Eye Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Eye Infections Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Eye Infections Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Eye Infections Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Eye Infections Treatment market.
Global Eye Infections Treatment Scope and Market Size
Eye Infections Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Eye Infections Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Gels & Creams
Eye drops
Drug
Segment by Application
Ophthalmology Clinics
Hospitals
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Allergan
Mercks
Novartis
Pfizer
Santen Pharmaceuticals
Valent
Bayer
GSK
Novartis
Pfizer
Eli Lilly
Novo Nordisk
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eye Infections Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gels & Creams
1.2.3 Eye drops
1.2.4 Drug
1.3 Market by Application
1.3.1 Global Eye Infections Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Ophthalmology Clinics
1.3.3 Hospitals
1.3.4 Retail Pharmacies
1.3.5 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Eye Infections Treatment Market Perspective (2016-2027)
2.2 Eye Infections Treatment Growth Trends by Regions
2.2.1 Eye Infections Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Eye Infections Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Eye Infections Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Eye Infections Treatment Industry Dynamic
2.3.1 Eye Infections Treatment Market Trends
2.3.2 Eye Infections Treatment Market Drivers
2.3.3 Eye Infections Treatment Market Challenges
2.3.4 Eye Infections Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Eye Infections Treatment Players by Revenue
3.1.1 Global Top Eye Infections Treatment Players by Revenue (2016-2021)
3.1.2 Global Eye Infections Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Eye Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Eye Infections Treatment Revenue
3.4 Global Eye Infections Treatment Market Concentration Ratio
3.4.1 Global Eye Infections Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eye Infections Treatment Revenue in 2020
3.5 Eye Infections Treatment Key Players Head office and Area Served
3.6 Key Players Eye Infections Treatment Product Solution and Service
3.7 Date of Enter into Eye Infections Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Eye Infections Treatment Breakdown Data by Type
4.1 Global Eye Infections Treatment Historic Market Size by Type (2016-2021)
4.2 Global Eye Infections Treatment Forecasted Market Size by Type (2022-2027)
5 Eye Infections Treatment Breakdown Data by Application
5.1 Global Eye Infections Treatment Historic Market Size by Application (2016-2021)
5.2 Global Eye Infections Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Eye Infections Treatment Market Size (2016-2027)
6.2 North America Eye Infections Treatment Market Size by Type
6.2.1 North America Eye Infections Treatment Market Size by Type (2016-2021)
6.2.2 North America Eye Infections Treatment Market Size by Type (2022-2027)
6.2.3 North America Eye Infections Treatment Market Size by Type (2016-2027)
6.3 North America Eye Infections Treatment Market Size by Application
6.3.1 North America Eye Infections Treatment Market Size by Application (2016-2021)
6.3.2 North America Eye Infections Treatment Market Size by Application (2022-2027)
6.3.3 North America Eye Infections Treatment Market Size by Application (2016-2027)
6.4 North America Eye Infections Treatment Market Size by Country
6.4.1 North America Eye Infections Treatment Market Size by Country (2016-2021)
6.4.2 North America Eye Infections Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Eye Infections Treatment Market Size (2016-2027)
7.2 Europe Eye Infections Treatment Market Size by Type
7.2.1 Europe Eye Infections Treatment Market Size by Type (2016-2021)
7.2.2 Europe Eye Infections Treatment Market Size by Type (2022-2027)
7.2.3 Europe Eye Infections Treatment Market Size by Type (2016-2027)
7.3 Europe Eye Infections Treatment Market Size by Application
7.3.1 Europe Eye Infections Treatment Market Size by Application (2016-2021)
7.3.2 Europe Eye Infections Treatment Market Size by Application (2022-2027)
7.3.3 Europe Eye Infections Treatment Market Size by Application (2016-2027)
7.4 Europe Eye Infections Treatment Market Size by Country
7.4.1 Europe Eye Infections Treatment Market Size by Country (2016-2021)
7.4.2 Europe Eye Infections Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Eye Infections Treatment Market Size (2016-2027)
8.2 Asia-Pacific Eye Infections Treatment Market Size by Type
8.2.1 Asia-Pacific Eye Infections Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Eye Infections Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Eye Infections Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Eye Infections Treatment Market Size by Application
8.3.1 Asia-Pacific Eye Infections Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Eye Infections Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Eye Infections Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Eye Infections Treatment Market Size by Region
8.4.1 Asia-Pacific Eye Infections Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Eye Infections Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Eye Infections Treatment Market Size (2016-2027)
9.2 Latin America Eye Infections Treatment Market Size by Type
9.2.1 Latin America Eye Infections Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Eye Infections Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Eye Infections Treatment Market Size by Type (2016-2027)
9.3 Latin America Eye Infections Treatment Market Size by Application
9.3.1 Latin America Eye Infections Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Eye Infections Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Eye Infections Treatment Market Size by Application (2016-2027)
9.4 Latin America Eye Infections Treatment Market Size by Country
9.4.1 Latin America Eye Infections Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Eye Infections Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Eye Infections Treatment Market Size (2016-2027)
10.2 Middle East & Africa Eye Infections Treatment Market Size by Type
10.2.1 Middle East & Africa Eye Infections Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Eye Infections Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Eye Infections Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Eye Infections Treatment Market Size by Application
10.3.1 Middle East & Africa Eye Infections Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Eye Infections Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Eye Infections Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Eye Infections Treatment Market Size by Country
10.4.1 Middle East & Africa Eye Infections Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Eye Infections Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Eye Infections Treatment Introduction
11.1.4 Roche Revenue in Eye Infections Treatment Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Eye Infections Treatment Introduction
11.2.4 Allergan Revenue in Eye Infections Treatment Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Mercks
11.3.1 Mercks Company Details
11.3.2 Mercks Business Overview
11.3.3 Mercks Eye Infections Treatment Introduction
11.3.4 Mercks Revenue in Eye Infections Treatment Business (2016-2021)
11.3.5 Mercks Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Eye Infections Treatment Introduction
11.4.4 Novartis Revenue in Eye Infections Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Eye Infections Treatment Introduction
11.5.4 Pfizer Revenue in Eye Infections Treatment Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Santen Pharmaceuticals
11.6.1 Santen Pharmaceuticals Company Details
11.6.2 Santen Pharmaceuticals Business Overview
11.6.3 Santen Pharmaceuticals Eye Infections Treatment Introduction
11.6.4 Santen Pharmaceuticals Revenue in Eye Infections Treatment Business (2016-2021)
11.6.5 Santen Pharmaceuticals Recent Development
11.7 Valent
11.7.1 Valent Company Details
11.7.2 Valent Business Overview
11.7.3 Valent Eye Infections Treatment Introduction
11.7.4 Valent Revenue in Eye Infections Treatment Business (2016-2021)
11.7.5 Valent Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Eye Infections Treatment Introduction
11.8.4 Bayer Revenue in Eye Infections Treatment Business (2016-2021)
11.8.5 Bayer Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Eye Infections Treatment Introduction
11.9.4 GSK Revenue in Eye Infections Treatment Business (2016-2021)
11.9.5 GSK Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Eye Infections Treatment Introduction
11.10.4 AstraZeneca Revenue in Eye Infections Treatment Business (2016-2021)
11.10.5 AstraZeneca Recent Development
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Details
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Eye Infections Treatment Introduction
11.11.4 Daiichi Sankyo Revenue in Eye Infections Treatment Business (2016-2021)
11.11.5 Daiichi Sankyo Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Eye Infections Treatment Introduction
11.12.4 Eli Lilly Revenue in Eye Infections Treatment Business (2016-2021)
11.12.5 Eli Lilly Recent Development
11.13 Novo Nordisk
11.13.1 Novo Nordisk Company Details
11.13.2 Novo Nordisk Business Overview
11.13.3 Novo Nordisk Eye Infections Treatment Introduction
11.13.4 Novo Nordisk Revenue in Eye Infections Treatment Business (2016-2021)
11.13.5 Novo Nordisk Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Eye Infections Treatment Introduction
11.14.4 Sanofi Revenue in Eye Infections Treatment Business (2016-2021)
11.14.5 Sanofi Recent Development
11.15 GSK
11.15.1 GSK Company Details
11.15.2 GSK Business Overview
11.15.3 GSK Eye Infections Treatment Introduction
11.15.4 GSK Revenue in Eye Infections Treatment Business (2016-2021)
11.15.5 GSK Recent Development
11.16 Bausch＆Lomb
11.16.1 Bausch＆Lomb Company Details
11.16.2 Bausch＆Lomb Business Overview
11.16.3 Bausch＆Lomb Eye Infections Treatment Introduction
11.16.4 Bausch＆Lomb Revenue in Eye Infections Treatment Business (2016-2021)
11.16.5 Bausch＆Lomb Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Eye Infections Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gels & Creams
Table 3. Key Players of Eye drops
Table 4. Key Players of Drug
Table 5. Global Eye Infections Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Eye Infections Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Eye Infections Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Eye Infections Treatment Market Share by Regions (2016-2021)
Table 9. Global Eye Infections Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Eye Infections Treatment Market Share by Regions (2022-2027)
Table 11. Eye Infections Treatment Market Trends
Table 12. Eye Infections Treatment Market Drivers
Table 13. Eye Infections Treatment Market Challenges
Table 14. Eye Infections Treatment Market Restraints
Table 15. Global Eye Infections Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Eye Infections Treatment Market Share by Players (2016-2021)
Table 17. Global Top Eye Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eye Infections Treatment as of 2020)
Table 18. Ranking of Global Top Eye Infections Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Eye Infections Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Eye Infections Treatment Product Solution and Service
Table 22. Date of Enter into Eye Infections Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Eye Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Eye Infections Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Eye Infections Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Eye Infections Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Eye Infections Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Eye Infections Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Eye Infections Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Eye Infections Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Eye Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Eye Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Eye Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Eye Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Eye Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Eye Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Eye Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Eye Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Eye Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Eye Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Eye Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Eye Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Eye Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Eye Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Eye Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Eye Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Eye Infections Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Eye Infections Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Eye Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Eye Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Eye Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Eye Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Eye Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Eye Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Eye Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Eye Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Eye Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Eye Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Eye Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Eye Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Eye Infections Treatment Product
Table 65. Roche Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Allergan Company Details
Table 68. Allergan Business Overview
Table 69. Allergan Eye Infections Treatment Product
Table 70. Allergan Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 71. Allergan Recent Development
Table 72. Mercks Company Details
Table 73. Mercks Business Overview
Table 74. Mercks Eye Infections Treatment Product
Table 75. Mercks Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 76. Mercks Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Eye Infections Treatment Product
Table 80. Novartis Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Eye Infections Treatment Product
Table 85. Pfizer Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 86. Pfizer Recent Development
Table 87. Santen Pharmaceuticals Company Details
Table 88. Santen Pharmaceuticals Business Overview
Table 89. Santen Pharmaceuticals Eye Infections Treatment Product
Table 90. Santen Pharmaceuticals Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 91. Santen Pharmaceuticals Recent Development
Table 92. Valent Company Details
Table 93. Valent Business Overview
Table 94. Valent Eye Infections Treatment Product
Table 95. Valent Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 96. Valent Recent Development
Table 97. Bayer Company Details
Table 98. Bayer Business Overview
Table 99. Bayer Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 100. Bayer Recent Development
Table 101. GSK Company Details
Table 102. GSK Business Overview
Table 103. GSK Eye Infections Treatment Product
Table 104. GSK Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 105. GSK Recent Development
Table 106. AstraZeneca Company Details
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Eye Infections Treatment Product
Table 109. AstraZeneca Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 110. AstraZeneca Recent Development
Table 111. Daiichi Sankyo Company Details
Table 112. Daiichi Sankyo Business Overview
Table 113. Daiichi Sankyo Eye Infections Treatment Product
Table 114. Daiichi Sankyo Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 115. Daiichi Sankyo Recent Development
Table 116. Eli Lilly Company Details
Table 117. Eli Lilly Business Overview
Table 118. Eli Lilly Eye Infections Treatment Product
Table 119. Eli Lilly Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 120. Eli Lilly Recent Development
Table 121. Novo Nordisk Company Details
Table 122. Novo Nordisk Business Overview
Table 123. Novo Nordisk Eye Infections Treatment Product
Table 124. Novo Nordisk Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 125. Novo Nordisk Recent Development
Table 126. Sanofi Company Details
Table 127. Sanofi Business Overview
Table 128. Sanofi Eye Infections Treatment Product
Table 129. Sanofi Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 130. Sanofi Recent Development
Table 131. GSK Company Details
Table 132. GSK Business Overview
Table 133. GSK Eye Infections Treatment Product
Table 134. GSK Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 135. GSK Recent Development
Table 136. Bausch＆Lomb Company Details
Table 137. Bausch＆Lomb Business Overview
Table 138. Bausch＆Lomb Eye Infections Treatment Product
Table 139. Bausch＆Lomb Revenue in Eye Infections Treatment Business (2016-2021) & (US$ Million)
Table 140. Bausch＆Lomb Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Eye Infections Treatment Market Share by Type: 2020 VS 2027
Figure 2. Gels & Creams Features
Figure 3. Eye drops Features
Figure 4. Drug Features
Figure 5. Global Eye Infections Treatment Market Share by Application: 2020 VS 2027
Figure 6. Ophthalmology Clinics Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Eye Infections Treatment Report Years Considered
Figure 11. Global Eye Infections Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Eye Infections Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Eye Infections Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Eye Infections Treatment Market Share by Regions (2022-2027)
Figure 15. Global Eye Infections Treatment Market Share by Players in 2020
Figure 16. Global Top Eye Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eye Infections Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Eye Infections Treatment Revenue in 2020
Figure 18. Global Eye Infections Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Eye Infections Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Eye Infections Treatment Market Share by Type (2016-2027)
Figure 22. North America Eye Infections Treatment Market Share by Application (2016-2027)
Figure 23. North America Eye Infections Treatment Market Share by Country (2016-2027)
Figure 24. United States Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Eye Infections Treatment Market Share by Type (2016-2027)
Figure 28. Europe Eye Infections Treatment Market Share by Application (2016-2027)
Figure 29. Europe Eye Infections Treatment Market Share by Country (2016-2027)
Figure 30. Germany Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Eye Infections Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Eye Infections Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Eye Infections Treatment Market Share by Region (2016-2027)
Figure 40. China Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Eye Infections Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Eye Infections Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Eye Infections Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Eye Infections Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Eye Infections Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Eye Infections Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Eye Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 60. Allergan Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 61. Mercks Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 64. Santen Pharmaceuticals Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 65. Valent Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 67. GSK Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 69. Daiichi Sankyo Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 71. Novo Nordisk Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 72. Sanofi Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 73. GSK Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 74. Bausch＆Lomb Revenue Growth Rate in Eye Infections Treatment Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の壊死性皮膚感染症治療市場規模・現状・予測（2021年-2027年） Necrotizing skin infections ranks among the most rarely found diseases but are highly lethal infection. Necrotizing skin infection arise primarily in any layer of skin soft tissue such as dermis and epidermis that are associated with necrotizing changes. Necrotizing skin infection is also commonly c…- 世界の院内感染症（HAI）診断市場規模・現状・予測（2021年-2027年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…
- 世界の院内感染症管理市場規模・現状・予測（2021年-2027年） Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acq…
- 世界の院内感染症管理市場規模・現状・予測（2021年-2027年） Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acq…
- 世界の血液透過性感染症検査市場規模・現状・予測（2021年-2027年） Hemotransmissive Infections are the infections which are transferred through blood when infected person comes in contact. Severe diseases such as hepatitis C, hepatitis B and human immunodeficiency virus (HIV) are most common diseases spread via blood. Timely diagnosis of these diseases becomes impo…